Developmental Cell, Volume 22
Supplemental Information
Genetic Framework of Cyclin-Dependent
Kinase Function in Arabidopsis
Moritz K. Nowack, Hirofumi Harashima, Nico Dissmeyer, Xin’Ai Zhao, Daniel Bouyer,
Annika K. Weimer, Freya De Winter, Fang Yang, and Arp Schnittger
Inventory of supplemental data
Figure S1. Embryo development in cdka;1 and cdka;1 cdkb1;1 mutants.
Figure S2. Columella fate in cdka;1 mutants and rescue plants.
Figure S3. RBR1 ChIP of CDKB1;2 promoter fragments.
Figure S4. Temperature-dependent and dosage-sensitive overproliferation in the rbr1-2 allele.
Supplemental Experimental Procedures
Supplemental References
Figure S1. Embryo development in cdka;1 and cdka;1 cdkb1;1 mutants.
(A-E) Embryo development in the wild type from globular (A) over torpedo (B, C) to mature
green stage (D,E).
(F-J) Embryo development in a heterozygous cdka;1 mutant showing a class of embryos with
fewer and larger cells from globular (F) over torpedo (G, H) to mature green stage (I, J).
Note the increased cell size in cdka;1 mutant embryos (compare C and H, and E and J). Seed
size and endosperm proliferation are not affected in the seeds containing homozygous mutant
offspring. Seeds shown in A and F are developing in homozygous cdka;1-/-
mutants rescued
by a hemizygous PROCDKA;1:CDKA;1:YFP tracer construct, mimicking the heterozygous
cdka;1+/-
mutant phenotype. Segregating homozygous mutant embryos and endosperms can
be recognized by the absence of a YFP signal.
(K-P) Whole-mount seeds at different stages of development. Wild type at 21 days after
flowering (daf, K), early arrested embryos in cdka;1 cdkb1;1 mutant seeds at 7 daf (L-M),
later arrested embryo in cdka;1 cdkb1;1 mutant seeds at 10 daf (N), embryos in cdka;1
cdkb1;1 mutant seeds at 14 daf (O) and 21 daf (P). The arrowhead points at the embryos
inside the seeds.
(Q-V) Isolated embryo of the wild type (Q) or close-up of arrested embryos in cdka;1
cdkb1;1 mutant seeds, and an isolated cdka;1 cdkb1;1 mutant embryo at 21 days after
fertilization (V). (R-U) each are details of (L-O), respectively.
(W-X) PCR-based genotyping of mature embryos segregating from a heterozygous cdka;1+/-
mutant mother plant. Embryos with a wild-type phenotype were either CDKA;1+/+
wild type
or cdka;1+/-
heterozygous mutants (W, boxed lanes). Embryos with a cdka;1 phenotype did
not yield any CDKA;1 wild-type PCR product, and most showed a cdka;1 mutant PCR
product (X, boxed lanes). Note that the PCR sometimes failed, probably due to the low
amount of genomic DNA delivered by the few celled mutant embryos.
Scale bars, 100 µm (A-B, D, F-G, I, K-Q, V), 50 µm (E, J), and 20 µm (C, E, H, J, R-U).
Figure S2. Columella fate in cdka;1 mutants and rescue plants.
(A-D) Initially correctly specified tissue identity in cdka1 mutant root tips despite the severely
disturbed cellular pattern. J2341 and J1092 mark columella initials, and columella and lateral
root cap in the wild type (A, C) and in the cdka;1 mutant (B, D), respectively.
(E-H) Purple Lugol staining of starch grains revealing correctly specified columella cells in
the wild type (E), while starch grains are absent from arrested cdka;1 root tips (F). cdka;1
mutants rescued by co-depletion of RBR in a double homozygous cdka;1 rbr1-2 mutant (G)
or complemented with a PROCDKA;1:CDKB1;1 construct (H) show a reconstitution of lastingly
maintained columella fate.
Scale bars, 20 µm.
Figure S3. RBR1 ChIP of CDKB1;2 promoter fragments.
(A) Different pairs of overlapped primers (1 to 8) designed at approximately 1.14 kb upstream
of the region of the CDKB1;2-coding site because of the lack of predicted E2F-binding motif.
(B) ChIP PCR showing the interaction between the RBR1 protein and different fragments of
the CDKB1;2 promoter. (C) Potential E2F-binding motifs found in the CDKB1;2 promoter
region. Degenerated motifs WTTSSSSS and WCTSSSSS (W being A or T and S being C or
G) were not found in CDKB1;2 promoter, except one and two SSSSS motifs located within
the fragment 5 and 7, respectively. The fragments containing the potential E2F-binding motif
and the corresponding motifs are highlighted in red.
Figure S4. Temperature-dependent and dosage-sensitive overproliferation in the rbr1-2 allele.
The overproliferation phenotype and the degree of cdka;1 mutant rescues caused by the rbr1-
2 allele is temperature- and dosage-dependent. (A-C) Grown at 22°C, wild type (A) and rbr1-
2-/-
mutant plants (B, C) are hardly distinguishable. Only small areas of overproliferating cells
can be seen in rbr1-2-/-
mutants (C, arrowhead). (D-F) Grown at 17°C, wild type plants (D)
are largely similar to wild type plants grown at 22°C (compare A and D). rbr1-2-/-
mutants,
however, show areas with excessive epidermal overproliferation on their leaves,
macroscopically visible as white patches (E, arrowheads). Under the raster-electron
microscope the white patches resolve into areas with densely over-proliferated epidermal cell
clusters, separated by large epidermal pavement cells (F).
(G-I) Dosage dependent cdka;1 rbr1-2 rescue phenotype. When compared to the wild type
(G), a double homozygous cdka;1-/-
rbr1-2-/-
mutant grown at 17°C shows small serrated
leaves, islands of strongly over-proliferating cells (H, arrowheads, see inset for detail) and a
generally slightly smaller plant body (H). The homo-heterozygous cdka;1-/-
rbr1-2+/-
double
mutant, however, remains much smaller than the wild type or the double homozygous rescue,
and shows hardly any over-proliferation in epidermal cells (I).
Scale bars, 750 µm (A, C, D, F), 5 mm (B, E), 1 cm (G-I).
Supplemental Experimental Procedures
Isolation of cdkb1 mutant alleles:
The following alleles were isolated for CDKB1;1 (At3g54180): cdkb1;1-1: SALK_073457
(N573457); cdkb1;1-2: SAIL_540_E02 (N879507 and CS879507); cdkb1;1-3:
SALK_044765 (N544765); and cdkb1;1-4 (SAIL_871_C10; N522275 and CS877559). For
CDKB1;2 (At2g38620), the following alleles were isolated: cdkb1;2-1: SALK_133560
(N633560); cdkb1;2-2: SALK_034570 (N534570). The resistances against selective agents
are silenced for cdkb1;1-3, cdkb1;2-1, and cdkb1;2-2, and partially silenced for cdkb1;1-1.
cdkb1;1-4 could not be germinated and was withdrawn from both NASC and ABRC
collections.
Primer sequences for genotyping T-DNA mutant insertions
primer sequence 5’ > 3’
T-DNA insertion
cdka;1-1 M212 TGTACAAGCGAATAAAGACATTTGAAGTACC
J504 GCGTGGACCGCTTGCTGCAACTCTCTCAGG
cdka;1-2 N031 CTACACTGAATTGGTAGCTCAAACTGTC
N034 CCAGATTCTCCGTGGAATTGCG
cdkb1;1-1 N185 TGGTTCACGTAGTGGGCCATCGCCCTGATA
N177 TGTCTTTGAGCAGCCATCTGTGTTG
cdkb1;2-1 N185 TGGTTCACGTAGTGGGCCATCGCCCTGATA
N178 TTTTTGTACTCAGGGCCGGCTTTAC
rbr1-2 M206 CTTCCACAGCCCGGTCGTTTC
J504 GCGTGGACCGCTTGCTGCAACTCTCTCAGG
rbr1-3 M211 CAGTACCAATTCAGCTGAGCA
M125 CCCATTTGGACGTGAATGTAGACAC
Wild type allele
cdka;1-1 N048 CAGATCTCTTCCTGGTTATTCACA
N049 TGTACAAGCGAATAAAGACATTTGA
cdka;1-2 N034 CCAGATTCTCCGTGGAATTGCG
N035 GGAGATCGACTCCATCGGGATC
cdkb1;1-1 N406 GCTTACCAATTGAGAACAACTGATTC
N177 TGTCTTTGAGCAGCCATCTGTGTTG
cdkb1;2-1 N178 TTTTTGTACTCAGGGCCGGCTTTAC
N278 GGTTCAAAACAAATTATCATCAACTAGG
rbr1-2 M206 CTTCCACAGCCCGGTCGTTTC
M207 GATTACCGCAGCATTCTAGTTGAACGC
rbr1-3 M206 CTTCCACAGCCCGGTCGTTTC
M217 TCTTCTCGCTTTGGTGAGTGT
Generation of cdk double and triple mutants:
The challenge to generate double and triple mutants of CDKA;1 and CDKB1 deficient plants
was the close linkage of CDKA;1 and CDKB1;1, and the lowered transmission of mutant
alleles through the male germ line. First, we generated a double heterozygous cdka;1+/-
cdkb1;1+/-
mutant by crossing a heterozygous cdka;1+/-
mutant as a seed parent with a
homozygous cdkb1;1-/-
mutant as a pollen parent. The such generated cdka;1+/-
cdkb1;1+/-
F1
plants carried the cdka;1 allele and the cdkb1;1 allele on different homologous chromosomes
(in trans). Next, we crossed these cdka;1+/-
cdkb1;1+/-
F1 plants as seed parents with wild-
type plants as pollen parents. In the resulting F2 generation, we selected for heterozygous
cdka;1+/-
cdkb1;1+/-
plants to identify individuals that, due to cross-over events, now carried
the cdka;1 allele and the cdkb1;1 allele on the same homologous chromosome (in cis). These
plants we then crossed as seed parents with homozygous cdkb1;1-/-
mutants as pollen parents
to obtain homo-heterozygous cdka;1+/-
cdkb1;1-/-
mutants in the F3 generation.
To obtain the triple mutant, we crossed these homo-heterozygous cdka;1+/-
cdkb1;1-/-
mutants as seed parents with double homozygous cdkb1;1-/-
cdkb1;2-/-
mutants as pollen
parents. In the F1 generation, we selected for triple cdka;1+/-
cdkb1;1-/-
cdkb1;2+/-
mutants.
Finally, we allowed these F1 plants to selfpollinate and obtained the triple hetero-homo-
homozygous cdka;1+/-
cdkb1;1-/-
cdkb1;2-/-
mutants in their progeny.
DNA work:
The coding sequences of CDKB1 and CDKB2 kinase genes were cloned via Gateway
Technology (Invitrogen) into a pAMPAT vector carrying a PROCDKA;1 promoter fragment
(Nowack et al., 2006).
Primer sequences for cloning of CDKB constructs
RNA work:
1. Semi-quantitative RT-PCR
For transcript analysis, total RNA was prepared with the RNeasy Mini Kit (Qiagen) and
cDNA synthesis was performed with SuperScript III RNase H reverse transcriptase
(Invitrogen) according to the manufacturer’s instructions.
Primer sequences for semi-quantitative RT-PCR
primer sequence 5’ > 3’
Generic cDNA primers J750 ATTCTAGAGGCCGAGGCGGCCGCCATG-
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVA
J751 ATTCTAGAGGCCGAGGCGGCCGCCATG-
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVC
J752 ATTCTAGAGGCCGAGGCGGCCGCCATG-
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVG
J753 ATTCTAGAGGCCGAGGCGGCCGCCATG-
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTVT
Gene primer sequence 5’ > 3’
CDKB1;1
(AT3G54180.1)
N315 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCCACCATGGA
GAAGTACGAGAAGCTAGAG
N225 GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAGAACTGAGACTTG
CDKB1;2
(AT2G38620.2)
N324 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCCACCATGGAGAAAT
ACGAGAAGCTCG
N227 GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAGAACTGAGATTTG
CDKB2;1
(AT1G76540.1)
N333 GGGACAAGTTTGTACAAAAAAGCAGGCTTCCCACCATGGACGAGGG
AGTTATAGCA
N229 GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAGAGAGAGGACTTTT
CTGGC
CDKB2;2
(AT1G20930.1)
N341 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCCACCATGGACAACAAT
GGAGTTAAACC
N231 GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAGAGAGAGGACTTG
Gene
CDKB1;1 N358 GATGTTATCAACATCGATCTATGTTG
N376 GATATGAAGCAATTGCTGAAACTCAG
N496 GTTCATTGCTGTATCTGTTGTCATCG
N497 CATCTCATTGCTACCACACCATTGTG
CDKB1;2 N361 CTTGCCTCCTAATCATCTCGGC
N362 GAAATACGAGAAGCTCGAAAAGG
N407 CCTTTTCGAGCTTCTCGTATTTC
N424 AGCGTGCGAGGGATTCAAATGTTAAACG
EF1 N373 ATGCCCCAGGACATCGTGATTTCAT
N374 TTGGCGGCACCCTTAGCTGGATCA
ACT2 N628 GGCTCCTCTTAACCCAAAGGC
N629 CACACCATCACCAGAATCCAGC
TUB2 N481 GAGCCTTACAACGCTACTCTGTCTGTC
N482 ACACCAGACATAGTAGCAGAAATCAAG
CDKA;1 full length M153 ATAGAATGAAGGAGATTACTGGTTTTATGCC
M152 GTGTGGAGTTTACTTCAGCTTTATTATTCAGG
Fragment 5' of the T-DNA insertion M152 GTGTGGAGTTTACTTCAGCTTTATTATTCAGG
M151 GCACCACATCCTGCAATTTGACAATG
Fragment 3'of the T-DNA insertion M153 ATAGAATGAAGGAGATTACTGGTTTTATGCC
M150 CTTCAAGATTTTCAGAATCATGGGAACTC
2. qRT-PCR and expression analysis
RNA extraction was performed using RNeasy Mini Kit (Qiagen). For qRT-PCR analysis at
least three biological replicates were used. RNA-concentration and purity was tested using
nanodrop-photometric quantification (Thermo Scientific) and RNA-integrity was verified by
running 0.5 µg of total RNA on 1.5% agarose TBE-gels to detect the 28S and 16S rRNA
bands. For each replicate 0.5 μg RNA was treated with DNAseI (MBI Fermentas) according
to the manual to avoid contamination of genomic DNA and subsequently processed to obtain
cDNA using poly T-primer and SuperScript III reverse transcriptase (invitrogen) according to
the manufacturer’s instructions. Remaining RNA was digested using RNAseH (Fermentas).
For negative control, all steps were followed in the same manner without adding the reverse
transcriptase. The resulting cDNA was used for Reverse Transcription (RT)-PCR or
quantitative Real Time-PCR (qRT-PCR) using the Roche LightCycler 480 system.
Oligonucleotides were designed using either Primer3Plus-design tool
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) or QuantPrime (qPCR
primer design tool: http://www.quantprime.de/main) and used in final concentration of 0.25
μM each. 3-4 biological replicates with 2-3 technical replicates per biological replicate were
analyzed in the qRT-PCR-experiments. Cq calling was done using the Second Derivative
Maximum method. Target specific efficiencies were calculated as the mean of all reaction
specific efficiencies for a given target. Reaction specific efficiencies were deduced using
LinRegPCR 7.4 (http://LinRegPCR.nl (Ramakers et al., 2003; Ruijter et al., 2009)). Data was
quality controlled, normalized against 3 reference genes (ACT7 (AT5G09810), EXP
(AT4G26410) , TIP41-like (AT4G34270) and statistically evaluated (One-Way Anova Test)
using qbasePLUS 2.1 (http://www.biogazelle.com/products/qbaseplus (Hellemans et al.,
2007)).
Primer sequences for quantitative RT-PCR and quantitative PCR of the RBR1 targets
qRT PCR RBR1 targets
Gene identifier sequence 5’ > 3’
ACT7 AT5G09810.1 forward GTTGCCATTCAGGCCGTTCTTTC
reverse CAGAATCGAGCACAATACCGGTTG
TIP41-like
AT4G34270.1 forward TGAACTGGCTGACAATGGAGTG
reverse CATGAGCTTGGCATGACTCTCAC
EF1A AT5G60390.1 forward TGTAACAAGATGGATGCCACCAC
reverse TCCCTCGAATCCAGAGATTGGC
PCNA1 AT1G07370.1 forward CGGTGACATTGGAACCGCTAAC
reverse TCACAATTGCATCTTCCGGCTTG
MCM2 AT1G44900.1 forward GATAGAGGAACTGCAGACAAAGGC
reverse TCGGCCATGATCCAACTCGAAG
MCM5 AT2G07690.1 forward AGCTACAGGAGAATCCGGAGGATG
reverse AGATGCCGATCAACTGAGAGAAGC
ORC1A AT4G14700.1 forward TCGGTTGTGATCTTGGTGAATGC
reverse GCTGCAGCTTCTGCAATCTGTG
ORC3 AT5G16690.1 forward ACTTGACCCAGAAGCACGTTACC
reverse TGTGAAGGTGAAAGATCCCTGAGC
CDKA;1 AT3G48750.1 forward ACTGGCCAGAGCATTCGGTATC
reverse TCGGTACCAGAGAGTAACAACCTC
CDKB1;1 AT3G54180.1 forward CAACTGGTGTTGACATGTGGTCTG
reverse TCAGTTGGTGTTCCTAGCAACCTG
CDKB1;2 AT2G38620.2 forward TGCCGAGATGATTAGGAGGCAAG
reverse GGGCTAAAGTCCTAAACTGGTTCC
CDC6 AT2G29680.1 forward AGGCTCTATGTGTCTGCAGGAG
reverse ACCACTTGACACTCTGGAACTGG
Primer sequences for quantitative RT-PCR and quantitative PCR for ChIP qPCR
qPCR ChIP
Gene transcript_identifier sequence 5’ > 3’
PCNA1 AT1G07370.1 forward TCTTAAAACGATTGAGGCCG
reverse AATCGTTTGCGGCTATTTTG
CDKB1;1 AT3G54180.1 forward GTTGCAGTTGTCACGAACGA
reverse CCACGTCACTTCGTTTTTCC CDKB1;2 AT2G38620.1 (ChIP
PCR) forward CTTTCCCCTTTACATAGAAC
reverse TCATTCCAATTTCATGTATGG
(ChIP PCR) forward CCATACATGAAATTGGAATGA
reverse GGACTGTGAACTCTTACTCA
(ChIP PCR) forward GAAACAACCCACCATTAATG
reverse TAATGTTCAATGTTTGGCAC
(ChIP Q-PCR) forward GTGCCAAACATTGAACATTA
reverse CTTGAAGAGTCGATCATTTC
(ChIP PCR) forward GCTCGAAGTTTCAACCAATT
reverse TTCAATTCATTATCCATGGTG
(ChIP PCR) forward GCTTTACATCAAAGATCATGC
reverse TTAACATTTGAATCCCTCGC
(ChIP PCR) forward TTATTGGTACGTGTGAAGCG
reverse TCGTATTTCTCCATTGATGG
(ChIP PCR) forward GACCCAAACAAAAAACATTCA
reverse GTGGTATACCTTCTTCGTCC
MCM2 AT1G44900.1 forward TAGTGAAAGCCCATACGATG
reverse CTATCTGTGTATTGTTTCCG
MCM5 AT2G07690.1 forward GTAGCGGGAAATAGCAATGG
reverse TCCATTTACCCGTCCATAGG
ORC1A AT4G14700.1 forward CTCTTACCCAAATTCATTTCC
reverse TGGAAGAAGAGGGATTTTAC
ORC3 AT5G16690.1 forward CCAATTCCGGTCTAGTCTGG reverse TGGAGCAATCGAAAACGACG LB25 AtenSAT
(Chr4 1673860-1674024)
forward GAGGACCCGATCTCCTTCAT
reverse CGAGAACACCCCTGATAACG
RB32.5 AtenSAT (Chr4 1774813-1774954)
forward CGAACACACGGATATGTTGC
reverse TGGTGATGTACTCGCTGTCAA
RB35 AtenSAT forward CACGATAGATCAATAGGATTGAGG
(Chr4 1777125-1777324)
reverse CACGATCGTATGAGTTAGCAACTTT
AtCDC6
AT2G29680.1 forward TTGTTCAAACCATAATGCGG
reverse CAAAGAGGGAAAAATGGAAG
3. Generation of amiRNA lines
Artificial micro-RNAs (amiRNAs) against CDKB1 genes were designed and cloned as
described (Schwab et al., 2006).
amiRNA sequences against CDKBs and primer sequences for amiRNA cloning
gene / construct amiRNA sequence sequence I miR-s 5’ > 3’ sequence II miR-a 5’ > 3’
CDKB1;1 (AT3G54180.1)
cdkb1;1-A (MN67)
TAAGAGTTAAGTCTTGCGGGT
gaTAAGAGTTAAGTCTTGCGGGTtctctcttttgtattcc
gaACCCGCAAGACTTAACTCTTAtcaaagagaatcaatga
cdkb1;1-B (MN68)
TCTTAGGGTAAACATGCCACT
gaTCTTAGGGTAAACATGCCACTtctctcttttgtattcc
gaAGTGGCATGTTTACCCTAAGAtcaaagagaatcaatga
cdkb1;1-C (MN69)
TCTGTCAAAATATGGGTGATG
gaTCTGTCAAAATATGGGTGATGtctctcttttgtattcc
gaCATCACCCATATTTTGACAGAtcaaagagaatcaatga
CDKB1;2 (AT2G38620.2 )
cdkb1;2-A (MN70)
TACGTGATAAGTCTTGCGCCT
gaTACGTGATAAGTCTTGCGCCTtctctcttttgtattcc
gaAGGCGCAAGACTTATCACGTAtcaaagagaatcaatga
cdkb1;2-B (MN71)
TATGCCATTACACCGGGCGAT
gaTATGCCATTACACCGGGCGATtctctcttttgtattcc
gaATCGCCCGGTGTAATGGCATAtcaaagagaatcaatga
cdkb1;2-C (MN72)
TAGACAATAAACTTGGGCCGT
gaTAGACAATAAACTTGGGCCGTtctctcttttgtattcc
gaACGGCCCAAGTTTATTGTCTAtcaaagagaatcaatga
both CDKB1s together
cdkb1-A (MN73) TGAAATTCTTTCGA
CTGGATT gaTGAAATTCTTTCGACTGGATTtctctcttttgtattcc
gaAATCCAGTCGAAAGAATTTCAtcaaagagaatcaatga
cdkb1-B (MN74) TAAACGAGATAGACATTGGAT
gaTAAACGAGATAGACATTGGATtctctcttttgtattcc
gaATCCAATGTCTATCTCGTTTAtcaaagagaatcaatga
cdkb1-C (MN75) TTGAAACTCAGAATAACCAGG
gaTTGAAACTCAGAATAACCAGGtctctcttttgtattcc
gaCCTGGTTATTCTGAGTTTCAAtcaaagagaatcaatga
4. RNA in situ hybridization
Sample preparations and in situ hybridizations were performed as described previously
(Müller et al., 2006). The STM and WUS probes contained the nucleotide sequences 78 to
1122 and 249 to 887, respectively, relative to the ATG. The sequences were cloned into
pGEM vectors in antisense orientation relative to the T7 promoter. Linearized plasmids were
used as templates for probe synthesis using T7 RNA polymerase according to the
manufacturer’s instructions (Ambion). Probes were not hydrolyzed. After the color reaction,
slides were mounted in 30% glycerol and photographed using DIC microscopy on a Zeiss
Axiophot microscope.
Protein work
1. p9ckshs1-sepharose, p10Cks1At-sepharose
To express and purify p10Cks1At, a fusion protein with the maltose-binding protein (MBP)
was generated. p10Cks1At was amplified with primers #263 and #192 followed by primers
#264 and #133 to conjugate a TEV recognition sequence and attB recombination sites,
respectively. The PCR product was cloned into the GATEWAY entry vector pDONR201
(Invitrogen) using BP Clonase II (Invitrogen). A recombination reaction was performed
between the entry clone and the destination vector pDEST-periHisMBP (Nallamsetty et al.,
2005) by using LR Clonase II (Invitrogen) and E. coli BL21-AI cells (Invitrogen) were
transformed with the resulting vector, pDEST-HisMBP-p10Cks1At. E. coli cells were grown
until OD600=0.6 and the production of the fusion protein was induced by adding 0.3 mM
IPTG and 0.2% arabinose for 6 h at 37ºC. Cells were harvested by centrifugation and re-
suspended in Ni-NTA binding buffer (50 mM NaH2PO4, 100 mM NaCl, 10% (v/v) glycerol,
25 mM imidazole, pH 8.0), and lysed by sonication. After addition of Triton X-100 to 0.2%,
the cell slurry was incubated at 4ºC and clarified by centrifugation. The supernatant was
passed through a column packed with Ni-NTA resin (Qiagen), which was washed sequentially
with Ni-NTA binding buffer, and eluted with HIS elution buffer (Ni-NTA binding buffer
containing 225 mM imidazole). The eluate was dialysed against TEV reaction buffer (50 mM
Tris-HCl, pH 8.0, 0.5 mM EDTA, 1 mM DTT). p10Cks1At was cleaved from HisMBP using
TEV protease which was purified as described (Kapust et al., 2001). The fragments were
separated by Ni-NTA column. The flow through fractions which contain cleaved p10Cks1At
proteins were concentrated with Ultra-15 (Millipore) and the buffer was exchanged to
coupling buffer (0.1 M NaHCO3, 0.5 M NaCl, pH 8.3) with a PD-10 column (GE Healthcare).
Purified p10Cks1At was coupled to CNBr-activated Sepharose 4B (GE Healthcare) at a
concentration of 3.5 mg/ml of gel according to the manufacturer’s instructions. p9ckshs1-
beads were prepared as described (Azzi et al., 1994).
2. GST-AtRBR1-His6
To express full-length AtRBR1, pGEX-4T-1 (GE Healthcare) was amplified with primers
#294 and #295 and self-ligated to introduce a hexa-histidine sequence (pGEX-His6). A full-
length AtRBR1 was amplified with primers #194 and #293. PCR products were digested with
BamHI and XhoI, and ligated into BamHI - XhoI sites of pGEX-His6. E. coli BL21-AI cells
were transformed with the resulting vector, pGEX-AtRBR-His6, and grown until OD600=0.6
at 37ºC. The culture was transferred to 18ºC and grown for 30 min. The production of the
fusion protein was induced by adding 0.3 mM IPTG and 0.2% arabinose overnight at 18ºC.
Cells were harvested by centrifugation and re-suspended in phosphate-buffered saline (PBS)
buffer (140 mM NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3), and
lysed by sonication. After addition of Triton X-100 to 0.2%, the cell slurry was incubated at
4ºC then clarified by centrifugation. The supernatant was passed through a column packed
with Glutathione-agarose (Sigma), which was washed sequentially with PBS, and eluted with
GST elution buffer (50 mM Tris-HCl, pH 8.0, 10 mM Glutathione). The eluate was
sequentially purified with a column packed with Ni-NTA resin. GST-AtRBR1-His6 was
eluted with HIS elution buffer and the buffer was exchanged to kinase buffer (50 mM Tris-
HCl, pH 7.5, 10 mM MgCl2, 1 mM EGTA) with a PD-10 column.
3. Preparation of CDK-cyclin complexes in E. coli
CYCA2;3 and CYCD3;1 in a Gateway entry vector pDNOR201 were kindly provided by
Lieven De Veylder. A recombination reaction was performed between the entry clone and the
destination vector pHGGWA (Busso et al., 2005) by using LR Clonase II to fuse a GST-tag.
CDK-CYCA2;3 and CDK-CYCD3;1 complexes were produced in E. coli co-expressing GST
fused to Saccharomyces cerevisiae Civ1p. All three proteins were co-expressed by
transforming an E. coli SoluBL21 strain with both plasmids, pCDFDuet-1, containing
StrepIII-CDK and GST-Civ1p, and pHGGWA, containing the respective cyclin. Expression
and purification of active cell cycle complexes was performed as described in detail in
Harashima and Schnittger (Harashima and Schnittger, submitted). In short, cells were grown
in 50 ml of LB medium containing ampicillin and spectinomycin to OD600 of 0.6, and
incubated for 30 min at 18ºC. The production of proteins was induced by adding IPTG to
0.3mM, cells were then cultured overnight at 18°C before being harvested by centrifugation.
The cell pellet was re-suspended in 2.5 mL Ni-NTA binding buffer and lysed by sonication.
After Triton X-100 was added to 0.2%, the cell slurry was sonicated followed by
centrifugation. The supernatant was passed through a column packed with 300 µL Ni-NTA
resin, which was washed sequentially with 3 ml Ni-NTA binding buffer, and eluted with 600
µL HIS elution buffer. The buffer was exchanged to kinase buffer containing protease
inhibitors cocktail (Roche) and Phos-STOP (Roche) with a PD Mini Trap G-25 column (GE
Healthcare).
4. Western Blot
cdka;1 mutants were grown in liquid half MS medium containing 1% sucrose, pH 5.8, then
harvested and frozen in liquid nitrogen. Plants were ground in the liquid nitrogen with a
mortar and a pestle. The resulting fine powder was suspended in either IP complete buffer
(Harashima et al., 2007), or IEF buffer (8 M Urea, 2 M Thiourea, 4% Chaps, 20 mM Tris-
HCl, pH 8.5). Cell debris was pelleted by centrifugation and protein concentration of the
supernatant was measured with a Bradford kit (Bio-Rad). After separating the proteins on the
SDS-PAGE gel, proteins were transferred onto the PVDF membrane in the Towbin buffer
with a wet blotting system (Bio-Rad), the membrane was then blocked with 5% non-fat dry
milk in TBST. To detect CDKA;1 proteins, the membrane was probed with a 1:5000 dilution
of anti-PSTAIRE monoclonal antibody (Sigma) and 1:10000 HRP-conjugated anti-mouse
antibody (KPL) in TBST. Enhanced chemoluminescent detection was performed with HRP
substrate (Millipore). To detect Strep-tag III fused CDK, the membrane was probed with a
1:250000 dilution of Strep-Tactin HRP (IBA) in TBST. To detect HisGST fused cyclins, the
membrane was probed with a 1:250000 dilution of anti-poly His-HRP (Sigma) in TBST.
5. Kinase assay
CKS-associated proteins purified from 300 µg plant extracts were processed for kinase assays
as described previously (Harashima et al., 2007) with Histone H1 (Millipore) or GST-
AtRBR1-His6 as a substrate. In the case of recombinant kinases, the equal amount of
CDKA;1 and CDKB1;1 were used by quantifying them by western blot with Strep-Tactin
HRP.
Primer sequences for cloning in protein work
gene primer sequence 5’ > 3’
p10Cks1At
133 GGGGACCACTTTGTACAAGAAAGCTGGGTTTACTTAACAAGCATGTTCTGAGCT
p10Cks1At
192 GGACTAGTTTACTTAACAAGCATGTTCTGAGCT
AtRBR1 194 GCGGGATCCATGGAAGAAGTTCAGCCTCCAGTG
p10Cks1At
263 GAGAATCTTTATTTTCAGGGGATGGGTCAGATCCAATACTCCGAGAAAT
p10Cks1At
264 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGAGAATCTTTATTTTCAGGGG
AtRBR1 293 CCGCTCGAGTGAATCTGTTGGCTCGGTTTTAAGG
pGEX-4T-1 294 CATCATCACCGTGACTGACTGACGATCTGC
pGEX-4T-1 295 ATGATGATGCGGCCGCTCGAGTCG
6. Root growth on Roscovitine
To determine the root growth, dry seeds were sterilized with chlorine gas from 75% (v/v) Eau
de Javel (Floreal, Hagen, Germany) and 25% (v/v) hydrochloric acid and were sown directly
on MS containing different concentrations of Roscovitine (98%, Sigma Aldrich). Roscovitine
powder was dissolved in MeOH. The elongation of the roots was marked daily and measured
with ImageJ as performed previously (Dissmeyer et al., 2009). Two biological replicates with
each two technical replicates each containing 15 plants were analyzed.
Supplemental References
Azzi, L., Meijer, L., Ostvold, A. C., Lew, J., and Wang, J. H. (1994). Purification of a 15-kDa
cdk4- and cdk5-binding protein. J Biol Chem 269, 13279-13288.
Busso, D., Delagoutte-Busso, B., and Moras, D. (2005). Construction of a set Gateway-based
destination vectors for high-throughput cloning and expression screening in Escherichia
coli. Anal Biochem 343, 313-321.
Dissmeyer, N., Weimer, A. K., Pusch, S., De Schutter, K., Kamei, C. L., Nowack, M.K.,
Novak, B., Duan, G. L., Zhu, Y. G., De Veylder, L., and Schnittger, A. (2009). Control of
cell proliferation, organ growth, and DNA damage response operate independently of
dephosphorylation of the Arabidopsis Cdk1 homolog CDKA;1. The Plant Cell 21, 3641-
3654.
Harashima, H., and Schnittger, A. (submitted). Robust reconstitution of active cell-cycle
control complexes from co-expressed proteins in bacteria.
Harashima, H., Shinmyo, A., and Sekine, M. (2007). Phosphorylation of threonine 161 in
plant cyclin-dependent kinase A is required for cell division by activation of its associated
kinase. Plant J 52, 435-448.
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F., and Vandesompele, J. (2007). qBase
relative quantification framework and software for management and automated analysis of
real-time quantitative PCR data. Genome Biol 8, R19.
Kapust, R. B., Tözsér, J., Fox, J. D., Anderson, D. E., Cherry, S., Copeland, T. D., and
Waugh, D. S. (2001). Tobacco etch virus protease: mechanism of autolysis and rational
design of stable mutants with wild-type catalytic proficiency. Protein Eng 14, 993-1000.
Müller, D., Schmitz, G., and Theres, K. (2006). Blind homologous R2R3 Myb genes control
the pattern of lateral meristem initiation in Arabidopsis. The Plant Cell 18, 586-597.
Nallamsetty, S., Austin, B. P., Penrose, K. J., and Waugh, D. S. (2005). Gateway vectors for
the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and
periplasm of Escherichia coli. Protein Sci 14, 2964-2971.
Nowack, M. K., Grini, P. E., Jakoby, M. J., Lafos, M., Koncz, C., and Schnittger, A. (2006).
A positive signal from the fertilization of the egg cell sets off endosperm proliferation in
angiosperm embryogenesis. Nat Genet 38, 63-67.
Ramakers, C., Ruijter, J. M., Deprez, R. H., and Moorman, A. F. (2003). Assumption-free
analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339,
62-66.
Ruijter, J. M., Ramakers, C., Hoogaars, W. M., Karlen, Y., Bakker, O., van den Hoff, M. J.,
and Moorman, A. F. (2009). Amplification efficiency: linking baseline and bias in the
analysis of quantitative PCR data. Nucleic Acids Res 37, e45.
Schwab, R., Ossowski, S., Riester, M., Warthmann, N., and Weigel, D. (2006). Highly
Specific Gene Silencing by Artificial MicroRNAs in Arabidopsis. Plant Cell.